Skip to main content

Table 1 Biological samples collected for nicotine and metabolite (NM) measurement and their rationale for collection in response to the research question

From: Higher blood nicotine concentrations following smokeless tobacco (pituri) and cigarette use linked to adverse pregnancy outcomes for Central Australian Aboriginal pregnancies

Biological sample

Rationale for collection

Maternal venous blood

- indicates recency of maternal nicotine exposure [62]

Umbilical vein cord blood

- indicates nicotine placental transfer (and foetal exposure) from the maternal circulatory system

Umbilical artery cord blood

-indicates foetal nicotine excretion via the circulatory system (and return to the mother)

Amniotic fluid

- demonstrates foetal nicotine exposure directly through the amniotic membrane, and foetal nicotine excretion via the foetal kidneys and lungs [11, 63,64,65]

Maternal urine

- indicates maternal nicotine excretion via urinary system [3]

Neonatal urine

- comparison of Day 1 and Day 3 urine with umbilical vein and umbilical artery cord bloods may demonstrate neonatal nicotine absorption, metabolism and excretion [18]

Colostrum and/or breast milk

- indicates nicotine excretion and possible route of post-birth nicotine exposure [66, 67]